I take this as a positive sign about our lead therapy, CDH17 CART for GI cancers.
Surely our CEO would not have the temerity to present at this conference on the topic of “advances in cart therapies for solid cancers”, if the trial wasn’t progressing well.
the company has presented at 3 conferences in the last few weeks….cause for optimism?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 17137000 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 28294475 | 26 |
View Market Depth
| Last trade - 09.01am 18/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |
Day chart unavailable